FDA Works to Boost Estrogen Patch Supply
The FDA is collaborating with manufacturers to increase the supply of estradiol transdermal patches following a surge in demand that strained availability across the United States. Companies are expanding production lines and adding shifts to address the shortages.
Xurve View
Insights:
Xurve View